FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Drug-Eluting Peripheral Transluminal Angioplasty Catheter

PMA: P160049 · Supplement: S019 · Decision Jul 15, 2022
Classifications
1
FEI Numbers
26
Registration Numbers
26

Basic Information

Device Name
Drug-Eluting Peripheral Transluminal Angioplasty Catheter
Trade Name
Stellarex 035 Drug Coated Balloon Percutaneous Transluminal Angioplasty Catheter
PMA Number
P160049
Supplement Number
S019
Device Class
FDA Class 3
Product Code
ONU
Generic Name
Drug-Eluting Peripheral Transluminal Angioplasty Catheter
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
July 15, 2022
Date Received
June 14, 2022
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

Change in supplier of a packaging material.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
ONU Drug-Eluting Peripheral Transluminal Angioplasty Catheter